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        Left ventricular remodeling after acute myocardial 
infarction (MI) promotes heart failure, which is 
an epidemic with high mortality and increasing 
prevalence (  1  ). Despite advances in medical and 
interventional therapy for MI, many surviving 
patients still develop heart failure. The process of 
infarct healing involves a complex cascade of 
molecular, cellular, and physiological responses 
that aff  ect prognosis by directly infl  uencing the 
pathologic and structural changes in the heart 
(  2  –  9  ). Thus, the mechanisms that regulate the 
myocardial response to ischemic injury continue 
to receive intense scrutiny. 
  In human and experimental MI, interruption 
of blood supply leads to rapid death of cardiac 
myocytes in the ischemic heart. Infl  ammatory 
signals recruit neutrophils to the infarct zone 
within 24 h, and monocytes/macrophages shortly 
thereafter. Together, these leukocytes degrade 
extracellular matrix constituents and macromole-
cules released by injured cells and aid clearance of 
dead cardiac myocytes and their debris. During 
this early phase, the weakened wall of the infarcted 
ventricle has heightened susceptibility to rupture 
and often causes sudden death when complicated 
by rupture of the ventricular septum, a papil-
lary muscle, or of the left ventricular free wall. 
After     5 d, monocytes/macro  phages and endo-
thelial cells coordinate angio genesis and promote 
blood supply in the forming granulation tissue. 
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  Healing of myocardial infarction (MI) requires monocytes/macrophages. These mononuclear 
phagocytes likely degrade released macromolecules and aid in scavenging of dead cardio-
myocytes, while mediating aspects of granulation tissue formation and remodeling. The 
mechanisms that orchestrate such divergent functions remain unknown. In view of the 
heightened appreciation of the heterogeneity of circulating monocytes, we investigated 
whether distinct monocyte subsets contribute in specifi  c ways to myocardial ischemic injury 
in mouse MI. We identify two distinct phases of monocyte participation after MI and 
propose a model that reconciles the divergent properties of these cells in healing. Infarcted 
hearts modulate their chemokine expression profi  le over time, and they sequentially and 
actively recruit Ly-6C  hi   and -6C  lo   monocytes via CCR2 and CX  3  CR1, respectively. Ly-6C  hi   
monocytes dominate early (phase I) and exhibit phagocytic, proteolytic, and infl  ammatory 
functions. Ly-6C  lo   monocytes dominate later (phase II), have attenuated infl  ammatory 
properties, and express vascular  –  endothelial growth factor. Consequently, Ly-6C  hi   mono-
cytes digest damaged tissue, whereas Ly-6C  lo   monocytes promote healing via myofi  broblast 
accumulation, angiogenesis, and deposition of collagen. MI in atherosclerotic mice with 
chronic Ly-6C  hi   monocytosis results in impaired healing, underscoring the need for a bal-
anced and coordinated response. These observations provide novel mechanistic insights into 
the cellular and molecular events that regulate the response to ischemic injury and identify 
new therapeutic targets that can infl  uence healing and ventricular remodeling after MI. 3038 MONOCYTE HETEROGENEITY IN MYOCARDIAL INFARCTION | Nahrendorf et al.
(F4/80/I-A  b  /CD11c)  hi   (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20070885/DC1). Longitudinal analy-
sis identifi  ed dynamic alterations in the relative proportions of 
these populations. First, the ischemic myocardium included 
predominantly monocytes, but not macrophages/dendritic 
cells, at least during the fi  rst week after coronary occlusion 
(  Fig. 1 B  ). Macrophages and/or dendritic cells prevailed again 
on day 16, after completion of the acute phase of healing, and 
the proportion of monocytes and macrophages/dendritic cells 
returned to baseline (  Fig. 1 B  ). Second, the relative propor-
tion of Ly-6C  hi   and -6C  lo   monocytes in injured myocardium 
varied strikingly over time; Ly-6C  hi   monocytes predomi-
nated from day 1 to 4 (    75% of all monocytes), whereas 
Ly-6C  lo   monocytes prevailed from day 5 onward (    75% of 
all monocytes,   Fig. 1 C  ). Importantly, the biphasic Ly-6C  hi  :
Ly-6C  lo   response pertained irrespective of monocyte diff  er-
entiation (Fig. S2). 
  As long recognized (  2, 3, 5  ), neutrophils accumulated 
early in injured myocardium (    10  5   cells/mg infarct tissue on 
day 1;   Fig. 1, D and G  ). Monocytes started to accumulate 
on day 1, remained in high and relatively stable numbers 
until day 7 (e.g.,     4  –  5   ×   10  4   cells/mg tissue), and dropped to 
levels comparable to those in noninjured hearts on day 16 
(    0.3   ×   10  4   cells/mg tissue;   Fig. 1, E and G  ). In contrast, 
macrophages remained in relatively low numbers from day 
1 to 7 (  <  1   ×   10  4   cells/mg tissue;   Fig. 1, E and G  ). These fi  nd-
ings suggest an active role for undiff  erentiated monocytes, or 
macrophages not yet fully diff  erentiated, and challenge our 
current thinking on the role of macrophages in the healing 
process. Furthermore, distinction between Ly-6C  hi   and -6C  lo   
monocytes showed biphasic and contrary kinetics of mobili-
zation during the week that followed myocardial infarction 
(  Fig. 1, F and G  ). The number of Ly-6C  hi   monocytes in in-
jured myocardium peaked on day 3 (    4   ×   10  4   cells/mg tissue) 
and waned thereafter (  <  0.5   ×   10  4   cells/mg tissue on day 7), 
whereas the number of Ly-6C  lo   monocytes peaked only on day 
7 (    2   ×   10  4   cells/mg tissue). Thus, myocardial infarction 
triggered the sequential mobilization of Ly-6C  hi   and -6C  lo   
monocytes. The relative abundance of Ly-6C  hi   and -6C  lo   cells 
in the healing tissue thus identifi  es two phases of the monocytic 
response, hereafter referred to as phase I and II. These phases 
characterize relatively late events (i.e., days after MI), as opposed to 
events occurring within the fi  rst hours and that have been a 
focus of a recent study (  34  ). 
  The injured myocardium sequentially recruits circulating 
Ly-6C  hi   and -6C  lo   monocytes through modulation 
of chemokine expression 
  Several mechanisms might explain the selective mobilization 
of Ly-6C  hi   monocytes during phase I and Ly-6C  lo   monocytes 
during phase II. For instance, the injured myocardium may 
recruit Ly-6C  hi   cells that convert into Ly-6C  lo   cells at the on-
set of phase II. The myocardium may also recruit circulating 
Ly-6C  hi   and -6C  lo   cells sequentially; a biphasic recruitment of 
monocytes could result from alterations in the relative number 
of these cells in peripheral blood and/or from preferential 
Type I collagen, which is synthesized by myofi  broblasts, 
strengthens the infarct and protects it against rupture. By 2  –  3 wk 
after MI, monocytes/macrophages disappear and granulation 
tissue matures into a scar with cross-linked collagen as its dom-
inant feature (for review see references [  2  –  5  ]). During this pro-
cess, the healing heart undergoes profound changes in ventricular 
geometry and function (  10, 11  ). Optimum outcome after MI 
depends on a coordinated healing response that balances debris 
removal with repair of the myocardial extracellular matrix. 
Adverse remodeling and excessive infl  ammation can both pro-
mote heart failure (  1, 12, 13  ). 
  Monocytes/macrophages persist for days in the infarct zone 
and contribute to infl  ammation, proteolysis, phagocytosis, an-
giogenesis, and collagen deposition (  14  –  22  ). These diverse and 
seemingly contrasting functions position the monocyte/macro-
phage as a central cellular protagonist and potential therapeutic 
target in wound healing and tissue repair after MI (  16  –  20, 23  ). 
The tension between host defense and repair mechanisms versus 
proinfl  ammatory properties of the mononuclear phagocyte in 
infarcting myocardium requires caution against indiscriminate 
targeting of monocytes/macrophages (  24, 25  ). 
  Monocytes, which are the circulating precursors of macro-
phages, display heterogeneity in both mouse and human 
(  26  –  30  ). In the mouse, Ly-6C  hi   (Gr1  hi  CCR2  +  CX  3  CR1  lo  ) 
monocytes effi   ciently infi  ltrate infl  ammatory sites and give 
rise to macrophages and dendritic cells in response to infl  am-
matory stimuli (  26, 27, 31  –  33  ). Their counterparts, Ly-6C  lo   
(Gr1  lo  CCR2    −   CX  3  CR1  hi  ) monocytes, accumulate at infl  am-
matory sites less effi   ciently and are thought to give rise to resi-
dent tissue cells. This study tested the hypotheses that Ly-6C  hi   
and -6C  lo   monocyte subsets commit to specifi  c functions while 
in circulation and promote disparate processes in the infarcting 
myocardium of mice. We report on a novel mechanism of the 
myocardial response to ischemic injury and identify targets for 
future therapies in myocardial wound healing. 
    RESULTS   
  The injured myocardium mobilizes Ly-6C  hi   and -6C  lo   
monocytes in two distinct phases 
  To identify the repertoire of monocytes and their lineage de-
scendants within the injured myocardium, we induced myo-
cardial infarction in C57BL/6 mice by permanent coronary 
artery ligation and analyzed single-cell suspensions of digested 
infarcts at diff  erent time points. Flow cytometry defi  ned mono-
cytes and their lineage descendants as CD11b  hi   (CD90/B220/
CD49b/NK1.1/Ly-6G)  lo   mononuclear cells, as previously re-
ported (  31  ). These were further divided into Ly-6C  hi   (F4/80/
I-A  b  /CD11c)  lo   monocytes, Ly-6C  lo   (F4/80/I-A  b  /CD11c)  lo   
monocytes, and Ly-6C  lo   (F4/80/I-A  b  /CD11c)  hi   macrophages/
dendritic cells (  Fig. 1 A  ).   Delineation between mono  cytes 
and macrophages was based on the observations that (a) pe-
ripheral blood contains mostly monocytes, but not macro-
phages; (b) heart tissue under steady-state conditions within the 
CD11b  hi   gate contains mostly F4/80  int  I-A  b+  CD11c  lo   cells, but 
not monocytes, as assessed by separate staining; and (c) mono-
cytes are (F4/80/I-A  b  /CD11c)  lo  , whereas macrophages are JEM VOL. 204, November 26, 2007 
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monocytes in mouse blood. Splenic monocytes were defi  ned 
as CD11b  hi   (CD90/B220/CD49b/NK1.1/Ly-6G)  lo   (F4/80/
I-A  b  /CD11c)  lo   to exclude resident macrophages and dendritic 
cells, and had the same morphology as blood monocytes (  31  ). 
Extensive analysis of splenic and blood monocytes also showed 
similar FSC, SSC, Ly-6C, CD11b, CD43, CD62L, CD68, 
CD86, CD115, Mac-3, F4/80/I-Ab/CD11c, Gr-1, CCR2, 
and CX  3  CR1 phenotype (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20070885/DC1), thus indicating 
that splenic monocytes can be used as a rich source of sur-
rogate circulating monocytes. Excising hearts 24 h after adop-
tive transfer and calculating percent-injected dose per gram of 
tissue revealed a similar intrinsic (i.e., on a cell  –  cell basis with-
out considering the endogenous, nonlabeled cell population) 
capacity of Ly-6C  hi   and -6C  lo   monocytes to infi  ltrate the in-
jured myocardium during phase I. Conversely, Ly-6C  lo   mono-
cytes showed a 4.8-fold increased capacity to enter hearts 
during phase II (  Fig. 2 C  ). Because exogenously labeled, adop-
tively transferred monocytes compete with the endogenous 
pool (  Fig. 2 D   and Table S1), we could calculate the relative 
contribution of Ly-6C  hi   and -6C  lo   cells recruited to the injured 
myocardium by taking into account the relative proportion of 
circulating Ly-6C  hi   and -6C  lo   monocytes (  Fig. 2 B  ) and their 
recruitment to the target tissue. To address these issues, we 
sought to determine how circulating Ly-6C  hi   and -6C  lo   mono-
cytes contribute to the pool of monocytes/macrophages in 
injured hearts, and we measured the following two parameters 
at the onset of phase I and II: (a) the relative abundance of 
Ly-6C  hi   and -6C  lo   monocytes in the blood, and (b) the intrinsic 
probability (i.e., on a cell  –  cell basis) of circulating Ly-6C  hi   and 
-6C  lo   monocytes being recruited to injured hearts. To this end, 
we fi  rst analyzed peripheral blood mononuclear cells ex vivo; 
although the total leukocyte numbers remained relatively 
stable over time (  Fig. 2 A  ), myocardial infarction triggered acute 
Ly-6C  hi   monocytosis during phase I, but not during phase II, 
whereas the number of circulating Ly-6C  lo   monocytes remained 
unchanged (  Fig. 2 B  ).   Thus, circulating Ly-6C  hi   monocytes 
became, on average, 4.5-fold more numerous than Ly-6C  lo   
monocytes in phase I, and then returned to relatively com-
parable abundance in phase II (  Fig. 2 B  ). Second, we measured 
the intrinsic capacity of monocytes to accumulate in the injured 
myocardium. This involved labeling equal numbers of fl  ow-
sorted splenic Ly-6C  hi   or -6C  lo   monocytes with   111  In-oxine, 
followed by intravenous injection of labeled cells into mice 
at the onset of either phase I or II. We used the spleen as 
a source of monocytes, because of the relative paucity of 
  Figure 1.     The ischemic myocardium mobilizes Ly-6C  hi   and -6C  lo   monocytes in two distinct phases. Cell suspensions from healthy hearts or in-
farcts of C57BL/6 mice were stained with anti-CD11b, -CD90, -B220, -CD49b, -NK1.1, -Ly-6G, -Ly-6C, -F4/80, -I-A  b  , and -CD11c mAbs. Monocytes/
macrophages/dendritic cells were identifi  ed as CD11b  hi   (CD90/B220/CD49b/NK1.1/Ly-6G) lo  . (A) Representative dot plots from individual mice within the 
monocyte/macrophage/dendritic cell gate depict Ly-6C  hi   monocytes  (Ly-6C hi   [F4/80/I-A b /CD11c] lo ),  Ly-6C lo   monocytes  (Ly-6C lo   [F4/80/I-A b /CD11c] lo ),  and 
macrophages/dendritic cells (Ly-6C  lo   [F4/80/I-A b /CD11c] hi  ) in healthy hearts and within the infarct at specifi  ed days after MI. Percentages of cells are 
shown as the mean   ±   the SEM. (B) Relative percentage of monocytes and macrophages/dendritic cells. (C) Relative percentage of Ly-6C  hi   and  -6C lo   mono-
cytes. (D) Total number of neutrophils per milligram of tissue. (E) Total number of monocytes and macrophages/dendritic cells per milligram of tissue. 
(F) Total number of Ly-6C  hi   and  -6C lo   monocytes per mg tissue. (G) Time course of leukocyte infi  ltration to infarct. The mean and the SEM are shown. 
Results are pooled from 6 independent experiments with 3  –  10 mice per group.     3040 MONOCYTE HETEROGENEITY IN MYOCARDIAL INFARCTION | Nahrendorf et al.
injured myocardium in phase II because the proportion of newly 
recruited Ly-6C  lo   monocytes (  Fig. 2 C  ) matched the proportion 
of Ly-6C  lo   monocytes present in the infarct (  Fig. 1 F  ). 
  Sequential recruitment of monocyte subsets to the infarct 
suggests coordinated orchestration by chemokines, leukocyte 
adhesion molecules, and their cognate receptors. We tested this 
hypothesis by measuring several candidate chemokines and an 
adhesion molecule previously implicated in directing mono-
cyte migration (  28, 33, 35  ). We found that MCP-1 mRNA 
levels peaked during phase I, MIP-1     levels increased to the 
same extent in phase I and II, fractalkine levels decreased only 
in phase I, and VCAM-1 levels increased only in phase II (  Fig. 
3 A  ).   Thus, the injured myocardium expresses distinct chemo-
kines and adhesion molecule in phases I and II. Interestingly, 
Ly-6C  hi   monocytes selectively express CCR2, a receptor for 
MCP-1, whereas Ly-6C  lo   monocytes express high levels of 
CX  3  CR1, which is a receptor for fractalkine (  Fig. 3 B   and ref-
erence [  26  ]). This fi  nding led us to propose that CCR2 or 
CX  3  CR1 support migration of Ly-6C  hi   cells in phase I and of 
Ly-6C  lo   cells in phase II, respectively. Testing these hypotheses 
involved analyzing monocyte recruitment to the wounded 
myocardium of CCR2    –  /  –    and CX  3  CR1    –  /  –    C57BL/6 mice 
(  Fig. 3 C  ). In phase I, Ly-6C  hi   monocytes accumulated effi   -
ciently in infarcts of wild-type and CX  3  CR1    –  /  –    mice; how-
ever, we noted a   >  50-fold decrease of Ly-6C  hi   monocytes in 
infarcts of CCR2    –  /  –    mice, indicating that early Ly-6C  hi   mono-
cyte accumulation depends on CCR2, but not CX  3  CR1. No-
tably, Ly-6C  hi   monocytes have impaired ability to leave the 
bone marrow of CCR2    –  /  –    mice (  35, 36  ); however, on day 1 
after MI, we observed only a 3.3-fold decrease in the number 
of Ly-6C  hi   monocytes in peripheral blood of CCR2    –  /  –    mice 
compared with wild-type mice; thus, decreased numbers of 
Ly-6C  hi   monocytes in infarcts result at least in part from im-
paired recruitment of peripheral blood monocytes. In phase II, 
Ly-6C  hi   monocytes remained in low numbers in infarcts of 
intrinsic capacity to migrate to wounded myocardium (  Fig. 2 C  ). 
We found that the injured myocardium preferentially recruited 
Ly-6C  hi   cells (78%) during phase I, and Ly-6C  lo   cells (80%) 
during phase II (  Fig. 2 E  ). 
  The mechanisms driving monocyte accumulation in hearts 
are diff  erent in phase I and II. The dominance of Ly-6C  hi   
monocytes in hearts in phase I is driven by selective expansion 
of circulating Ly-6C  hi   cells. This conclusion is in accordance 
with the fi  nding that Ly-6C  hi   monocytes accumulate abun-
dantly in hearts after injury (the mean   ±   the SD from 250   ±   
200 Ly-6C  hi   monocytes/mg of tissue before MI to 24,000   ±   
6,000 on day 1 after MI), whereas Ly-6C  lo   monocytes do so 
to a much lesser extent (from 1,400   ±   1,000 Ly-6C  lo   mono-
cytes/mg of tissue before MI to 5,800   ±   2,600 on day 1 
after MI). In contrast, the dominance of Ly-6C  lo   monocytes 
in hearts in phase II is driven by preferential recruitment of cir-
culating Ly-6C  lo   monocytes. These results also suggest that 
Ly-6C  hi     →   Ly-6C  lo   monocyte conversion rarely occurs in the 
  Figure 3.     Sequential recruitment of Ly-6C  hi   and -6C  lo   monocytes 
depends on CCR2 and CX  3  CR1, respectively. (A) RT-PCR expression 
profi  le of MCP-1, MIP-1    , fractalkine, and VCAM-1 in the heart tissue 
before MI and during phase I (day 1) and II (day 4). (B) Monocyte subset 
expression profi  le of CCR2, CCR5, CX  3  CR1 (for review see reference [  29  ]), 
and VLA-4 (as assessed by fl  ow cytometry). (C) Number of Ly-6C  hi   and 
-6C  lo   monocytes in infarcts of wild-type, CCR2   – / –   , and CX  3 CR1  – / –    mice  in 
phase I (day 1) and II (day 7). Numbers are normalized to milligrams of 
tissue. The mean and the SEM are shown.   n   =  3 – 5.  *,  P   <   0.05.   
  Figure 2.     The ischemic myocardium sequentially recruits circulat-
ing Ly-6C  hi   and -6C  lo   monocytes. (A) Number of total leukocytes in 
peripheral blood of C57BL/6 mice before MI and at the onset of phase I 
(day 1 after MI) and phase II (day 4). (B) Number of circulating Ly-6C  hi  
and -6C  lo   monocytes at the same time points. Values in the top right 
quadrants indicate the ratio between the two subsets. (C) In vivo cardiac 
accumulation of   111 In-oxine-labeled  Ly-6C hi   and  -6C lo   monocytes 24 h 
after adoptive transfer on day 0 (phase I) and day 4 (phase II). Values in 
the top right quadrants indicate the ratio between the two subsets. 
(D) Adoptively transferred   111 In-oxine – labeled  Ly-6C hi   monocytes  compete 
with endogenous Ly-6C  hi   monocytes. Increased numbers of endog-
enous circulating Ly-6C  hi   monocytes (x axis) decrease the ratio between 
transferred and endogenous Ly-6C  hi   monocytes (label frequency, y axis) 
that migrated into the peritoneal cavity of mice with peritonitis (Table S1). 
(E) Pie graph representing the relative proportion of Ly-6C  hi   and  -6C lo  
monocyte subsets expected to accumulate in infarct tissue, based on the 
mean abundance of each subset in peripheral blood (B) and the intrinsic 
capacity of circulating cells from each subset to accumulate at infarct 
tissue (C). Data represent three independent experiments and are shown 
as the mean   ±   the SEM. Table S1 is available at http://www.jem.org/cgi/
content/full/jem.20070885/DC1.   JEM VOL. 204, November 26, 2007 
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of various molecular imaging agents 1  –  7 d after MI to deter-
mine phagocytosis and proteinase activity in vivo (  22, 37, 38  ). 
Probes included fl  uorescent nanoparticles (CLIO-VT680) that 
are effi   ciently ingested by phagocytes, and activatable fl  uorescent 
sensors reporting either on cathepsin B, L, S (Prosense-680) 
or matrix metalloproteinases (MMPs)-2, -3, -9, and -13 
(MMPsense-680) activities. 1 d later, we analyzed monocytes 
freshly isolated from infarcts (  Fig. 4  ).   Both Ly-6C  hi   and -6C  lo   
monocytes exhibited equal phagocytic capacity in vivo. How-
ever, Ly-6C  hi  , but not Ly-6C  lo  , monocytes showed high 
  proteinase activity, a process involved in the breakdown of 
extracellular matrix. Ly-6C  hi  , but not -6C  lo  , monocytes also 
expressed the proinfl  ammatory cytokine TNF-    . Ly-6C  hi   
monocytes retrieved at diff  erent time points (days 1, 4, and 7) 
all produced TNF-     at comparable levels (unpublished data). 
Conversely, Ly-6C  lo   monocytes selectively expressed higher 
levels of vascular endothelial growth factor (VEGF). Thus, 
Ly-6C  hi   monocytes exhibit proteolytic and infl  ammatory func-
tions, whereas circulating Ly-6C  lo   monocytes have attenuated 
infl  ammatory and proangiogenic properties. The same pheno-
type in blood (unpublished data) and infarct for both Ly-6C  hi   
and -6C  lo   monocytes indicates that these cells commit for spe-
cifi  c functions while still in circulation and conserve these func-
tions in the ischemic myocardium. 
  In vivo relevance of the biphasic response to healing 
  The sequential recruitment of monocyte subsets to the in-
farct, combined with their diff  erential functional properties 
either wild-type, CCR2    –  /  –   , or CX  3  CR1    –  /  –    mice, as expected. 
Ly-6C  lo   monocytes were also found in low numbers during 
phase I in all mice tested. In phase II, Ly-6C  lo   monocytes ac-
cumulated effi   ciently in infarcts of wild-type and CCR2    –  /  –    
mice; however, we noted a sixfold decrease of Ly-6C  lo   
monocytes in infarcts of CX  3  CR1    –  /  –    mice indicating that late 
Ly-6C  lo   monocyte accumulation depends on CX  3  CR1, but 
not CCR2. Notably, we observed only a 0.9-fold decrease of 
circulating Ly-6C  lo   monocytes (and a 0.02-fold decrease of 
total monocytes) in CX  3  CR1    –  /  –    mice compared with wild-type 
mice on day 7 after MI, further indicating that Ly-6C  lo   mono-
cyte accumulation in infarcts at this time point is dependent 
on CX3CR1. Our data, however, do not exclude a role of 
CX3CR1 in cell survival. Altogether, these data indicate se-
quential recruitment of monocyte subsets to the infarct through 
coordinated orchestration of chemokines and their cognate re-
ceptors. These data also show that Ly-6C  hi    →  Ly-6C  lo   conver-
sion in tissue is unlikely because Ly-6C  hi   monocytes are nearly 
absent in infarcts of CCR2    –  /  –    mice in phase I, although Ly-6C  lo   
monocytes are present in phase II, and Ly-6C  hi   monocytes ef-
fi  ciently accumulate in infarcts of CX  3  CR1    –  /  –    mice in phase I, 
whereas Ly-6C  lo   monocytes do not in phase II. 
  Monocyte subsets exhibit differential functional properties 
  Having determined that Ly-6C  hi   and -6C  lo   monocytes se-
quentially enter the infarct, we next investigated whether 
these two subsets already commit for specifi  c functions. Mice 
subjected to coronary ligation received intravenous injections 
  Figure 4.     Ly-6C  hi   and -6C  lo   monocytes commit for different functions. Relative phagocytic activity, MMP activity, cathepsin activity, TNF-     pro-
duction (with or without stimulation with PMA/ionomycin), and VEGF expression in Ly-6C  hi   monocytes (shaded histogram), Ly-6C  lo   monocytes (black line), 
and control CD11b   –    cells (gray line) retrieved from the ischemic myocardium. The mean and the SEM are shown.   n   = 3  –  5. *, P   <   0.05; **, P   <   0.01.     3042 MONOCYTE HETEROGENEITY IN MYOCARDIAL INFARCTION | Nahrendorf et al.
monocyte counts in these mice (  31, 33  ). The persistence of 
large areas of debris and necrotic tissue detected by Masson 
trichrome staining, however, indicated impaired phagocytosis. 
Anti-CD31 staining detected increased numbers of microves-
sels in apoE    –  /  –    mice, but generation of new extracellular ma-
trix, as detected by diminished immunoreactive staining for 
    -actin and decreased staining with picrosirius red (PSR), was 
impaired (  Fig. 5 D  ). The broad deregulation of wound heal-
ing in apoE    –  /  –    mice, as indicated by these results, underscores 
the requirement for a balanced and coordinated monocyte re-
sponse, and raises the possibility that patients with atheroscle-
rosis and monocytosis likewise have impaired capacity for 
effi   cient myocardial healing. Impaired healing may result from 
increased numbers of Ly-6C  hi   monocytes mobilized in infarcts 
that prevent/delay the initiation of phase II, or by altered 
functions of Ly-6C  hi   and/or -6C  lo   monocytes that directly 
compromise healing of the myocardium. 
    DISCUSSION   
  This study tested the hypothesis that distinct monocyte sub-
types regulate left ventricular healing after MI, and documents 
a biphasic monocyte response to myocardial ischemic injury. 
Ly-6C  hi   monocytes accumulate via CCR2, dominate at the site 
of injury during the fi  rst 3 d (phase I), and scavenge necrotic 
debris by the combination of infl  ammatory mediator expression, 
proteolysis, and phagocytosis. Between 4 and 7 d after infarc-
tion (phase II), Ly-6C  lo   monocytes accumulate preferentially 
via CX  3  CR1 and promote reparative processes such as angio-
genesis and extracellular matrix deposition, the classical features 
of granulation tissue formation. These observations enrich our 
mechanistic understanding of how sequential mobilization of 
neutrophils, monocyte/macrophages, and fi  broblasts contribute 
to effi   cient healing; moreover, as a consequence of monocyte/
macrophage heterogeneity, these fi  ndings reveal distinct kinetic 
and functional properties of monocyte subsets. The biphasic 
response may have broad biological relevance beyond MI, es-
pecially because monocyte subsets commit for specifi  c func-
tion while still in circulation. 
  Previously, we investigated the role of monocytes in athero-
sclerosis (  31, 43  ), a disease that is initiated and perpetuated by 
chronic infl  ammation (  44  ). Continued feeding of a diet high in 
fat and cholesterol leads to progressive hypercholesterolemia-
associated monocytosis, during which Ly-6C  hi   monocytes con-
tinuously expand in the blood, actively accumulate in atheromata, 
and diff  erentiate into macrophages, whereas Ly-6C  lo   mono-
cytes infi  ltrate lesions less frequently (  31, 33  ). Infl  ammation 
that follows myocardial infarction, however, is acute and re-
solves within a few weeks. In this context, Ly-6C  hi   and -6C  lo   
monocytes infi  ltrate tissue sequentially. The noninfl  ammatory 
and proangiogenic properties of Ly-6C  lo   monocytes and their 
role in myocardial healing suggest that these cells actively 
participate in terminating infl  ammation. Whether these prop-
erties can be manipulated therapeutically in vivo, e.g., by 
obliterating Ly-6C  hi   monocytes, harnessing Ly-6C  lo   mono-
cytes, or promoting Ly-6C  hi     →   Ly-6C  lo   monocyte conver-
sion, remains to be determined. The chemokine/chemokine 
in circulation, suggests diff  erential roles in healing. Because 
both subsets are phagocytic, and because each phase occurs in 
a defi  ned time frame, we elected to investigate the impact of 
each phase on healing by depleting circulating monocytes 
with clodronate-loaded liposomes (Clo-Lip). Intravenous 
  injection of Clo-Lip depletes circulating monocytes with a 
nearly complete repopulation of the blood monocyte pool 
after 5  –  7 d (  21, 27  ). Use of this technique can therefore 
  defi  ne how kinetics and function of monocyte subsets co-
ordinate healing. Depletion of circulating monocytes during 
phase I involved Clo-Lip injection immediately after MI; 
  depletion during phase II involved Clo-Lip injection on day 3. 
Flow cytometry of infarct cell suspensions at the end of each 
phase showed a profound reduction of monocytes/macro-
phages, confi  rming that the injured myocardium actively re-
cruits circulating monocytes (  Fig. 5, A and B  ).  
  We then assessed the relevance of each phase to healing 
by evaluating cellular and molecular mediators in the infarct 7 d 
after MI ( Fig. 5 C ). Immunohistochemical analysis confi  rmed 
decreased numbers of Mac-3  +   monocytes/macrophages in 
infarcts of phase I and II  –  depleted animals. Depletion of phase I, 
but not phase II, resulted in larger areas of debris and ne-
crotic tissue, as indicated by Masson trichrome staining. Thus, 
removal of debris requires phase I and its accompanying in-
fl  ux of proteolytic and phagocytic Ly-6C  hi   monocytes imme-
diately after coronary artery ligation. The increased numbers 
of NIMP-R14  +   neutrophils in phase I  –  depleted   animals 
further indicates delayed or ineffi   cient removal of apop-
totic cells and necrotic tissue (  Fig. 5 C  ). Conversely, the 
hearts of mice that developed a native Ly-6C  hi   response in 
phase I, but that received Clo-Lip in phase II, showed de-
creased deposition of collagen as well as reduced numbers of 
microvascular     -actin  +   smooth muscle cells and CD31  +   endo-
thelial cells. Thus, granulation tissue formation and remodeling 
requires noninfl  ammatory, proangiogenic Ly-6C  lo   mono-
cytes during phase II (  Fig. 5 C  ). Of note, phase I  –  depleted 
animals also showed altered granulation tissue formation on 
day 7, under  scoring that phase I and II must occur in sequence. 
Thus, the Ly-6C  hi    –  dominant phase I involves proteolysis, 
infl  ammation, and phagocytosis for degradation and scav-
enging of damaged tissue, whereas the Ly-6C  lo    –  dominant 
phase II promotes myo  fi  broblast accumulation, angiogenesis, 
and deposition of collagen necessary for granulation tissue 
formation (Table S2, available at http://www.jem.org/cgi/
content/full/jem.20070885/DC1). 
  Atherosclerosis causes most MIs in humans. Leukocyte 
counts rise after clinical MI, and acute monocytosis is inde-
pendently associated with aneurysm formation, left ventricular 
dilation, and portends poor survival (  39, 40  ). Because apolipo-
protein E  –  defi  cient  (apoE    –  /  –   ) mice develop atherosclerosis, 
hyperlipidemia, and peripheral blood Ly-6C  hi   monocytosis 
when fed a diet high in fat and cholesterol (  31, 33, 41, 42  ), we 
investigated infarct healing in aged apoE    –  /  –    mice. Increased 
immunoreactive Mac-3 staining refl  ected increased monocyte/
macrophage recruitment to the wound, which is in accor-
dance with studies that documented elevated peripheral blood JEM VOL. 204, November 26, 2007 
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  Figure 5.     In vivo relevance of the biphasic response to healing. (A) Representative dot plots from individual mice depict Ly-6C  hi   monocytes 
  (bottom right), Ly-6C  lo   monocytes (bottom left), and macrophages/dendritic cells (top left) at the infarct after depletion of circulating monocytes with 
clodronate-loaded liposomes (Clo-Lip). Mice were analyzed on day 4 (Clo-Lip injection on day 0; depletion of phase I) and on day 7 (Clo-Lip injection on 
day 3; depletion of phase II). Control animals (    ) did not receive Clo-Lip. Percentages of cells are shown as the mean   ±   the SEM. (B) Total number of 
monocytes per milligram of tissue at the infarct before MI, at the end of phase I (day 4) and during phase II (day 7), in the absence (  –  ) or presence (+) of 
Clo-Lip. The mean and the SEM are shown.   n   = 3  –  5. (C) Immunohistochemical analysis 7 d after MI depicts representative infarct sections from undepleted 
(    ), phase I  –  depleted (I), and phase II  –  depleted (II) C57BL/6 mice. Representative sections stained with anti  –  Mac-3, anti  – NIMP-R14,  Masson,    -actin, 
PSR, and anti-CD31 are shown. The mean and the SEM are shown.   n   = 7. (D) Immunohistochemistry depicts representative infarct sections from apoE   – / –   
mice 7 d after MI. The mean and the SEM are shown.   n   = 5. *, P   <   0.05; **, P   <   0.01. Bars: (Mac-3, NIMP-R14,     -actin, and CD31) 20     m; (PSR and 
  Masson) 100    m.   3044 MONOCYTE HETEROGENEITY IN MYOCARDIAL INFARCTION | Nahrendorf et al.
    MATERIALS AND METHODS   
  Myocardial infarction in mice.     A total of 136 female C57BL6 mice 
(The Jackson Laboratory), 5 apoE    –  /  –    C57BL/6 mice (The Jackson Labora-
tory) consuming Western diet (21.2% fat/weight; 0.2% cholesterol; Harlan 
Teklad, Inc.), 10 CCR2    –  /  –    C57BL/6 mice, and 9 CX  3  CR1    –  /  –    C57BL/6 
mice were used in this study. Mice were 6  –  8 wk old, with the exception 
of apoE    –  /  –    mice that were 1 yr old. Myocardial infarction was induced by 
coronary ligation (  53  ). Mice were intubated and ventilated with isofl  urane sup-
plemented with oxygen (isofl  urane 1  –  2% vol/vol + 2 liters O  2  ). The chest 
wall was shaved and a thoracotomy was performed in the fourth left inter-
costal space. The left ventricle was visualized, and the left coronary artery 
was permanently ligated with a monofi  lament nylon 8  –  0 suture at the site of 
its emergence from under the left atrium. The thoracotomy was closed with 
sutures and superglue. The institutional subcommittee on research animal 
care at Massachusetts General Hospital approved all animal studies. 
  Cells.     Mice were killed 3 h and on days 1  –  5, 7, and 16 after myocardial 
  infarction (  n   = 3  –  10 mice per time point). Peripheral blood was drawn via 
cardiac puncture with citrate solution (100 mM Na-citrate, 130 mM glu-
cose, pH 6.5), as anti-coagulant and mononuclear cells were purifi  ed by 
density centrifugation (  43  ). Total blood leukocyte numbers were determined 
using acetic acid lysis solution (3% HEMA 3 Solution II, 94% ddH  2  O, and 
3% glacial acetic acid). Spleens were removed, triturated in HBSS (Mediatech, 
Inc.) at 4  °  C with the end of a 3-ml syringe, and fi  ltered through nylon mesh 
(BD Biosciences). The cell suspension was centrifuged at 300 g for 
10 min at 4  °  C. Red blood cells were lysed with ACK lysis buff  er, and the 
splenocytes were washed with HBSS and resuspended in HBSS supple-
mented with 0.2% (wt/vol) BSA and 1% (wt/vol) FCS. Infarct tissue and 
healthy hearts were harvested, minced with fi  ne scissors, and placed into a 
cocktail of collagenase I, collagenase XI, DNase I, and hyaluronidase (Sigma-
Aldrich) and shaken at 37  °  C for 1 h, as previously described (  54  ). Cells were 
then triturated through nylon mesh and centrifuged (15 min, 500   g  , 4  °  C). 
Total spleen and cardiac cell numbers were determined with Trypan blue 
(Mediatech, Inc.). The resulting single-cell suspensions were washed with 
HBSS supplemented with 0.2% (wt/vol) BSA and 1% (wt/vol) FCS. For 
morphologic characterizations, sorted cells were spun, resuspended in PBS, 
and prepared on slides by cytocentrifugation (Shandon, Inc.) at 10   g   for 2 min, 
and stained with HEMA-3 (Thermo Fischer Scientifi  c). 
  mAbs and fl  ow cytometry.     The following antibodies were used: anti  –
  CD90-PE, 53  –  2.1 (BD Biosciences),   –  B220-PE, RA3-6B2 (BD Biosci-
ences),  –  CD49b-PE, DX5 (BD Biosciences),   –  NK1.1-PE, PK136 (BD 
Biosciences),   –  Ly-6G-PE, 1A8 (BD Biosciences),   –  Ly-6G-FITC, 1A8 (BD 
Biosciences), CD11b-APC, M1/70 (BD Biosciences),   –  F4/80-biotin, C1:
A3-1 (AbD Serotec),  –  F4/80-FITC, C1:A3-1 (BioLegend),  –  CD11c-biotin, 
HL3 (BD Biosciences),   –  CD11c-FITC, HL3 (BD Biosciences),   –  I-A  b  -biotin, 
AF6-120.1 (BD Biosciences),   –  I-A  b  -FITC, AF6-120.1 (BD Biosciences), 
  –  Ly-6C-FITC, AL-21 (BD Biosciences),   –  Ly-6C-biotin, AL-21 (BD 
Biosciences), TNF-    -FITC, MP6-XT22 (AbD Serotec), anti-CD43-FITC, 
S7 (BD Biosciences),   –  CD62L-FITC, MEL-14 (BD Biosciences),   –  CD68-
FITC, FA-11 (AbD Serotec),   –  CD86-biotin, GL1 (BD Biosciences), 
  –  CD115-PE, 604B5-2E11 (AbD Serotec),   –  Mac-3-FITC, M3/84 (BD Biosci-
ences),   –  Gr-1-PeCy7, RB6-8C5 (BD Biosciences). Strep-PerCP (BD Bio-
sciences) was used to label biotinylated antibodies. Monocytes were identifi  ed 
as CD11b  hi   (CD90/B220/CD49b/NK1.1/Ly-6G)  lo   (F4/80/I-A  b  /CD11c)  lo   
Ly-6C  hi/lo  . Macrophages/dendritic cells were identifi  ed as CD11b  hi   (CD90/
B220/CD49b/NK1.1/Ly-6G)  lo   (F4/80/I-A  b  /CD11c)  hi   Ly-6C  lo  . Neutrophils 
were identifi  ed as CD11b  hi   (CD90/B220/CD49b/NK1.1/Ly-6G)  hi   (F4/80/
I-A  b  /CD11c)  lo   Ly-6C  int  . Monocyte and macrophage/dendritic cell numbers 
were calculated as the total cells multiplied by the percentage of cells within 
the monocyte/macrophage gate. Within this population, monocyte subsets 
were identifi  ed as (F4/80/I-A  b  /CD11c)  lo   and either Ly-6C  hi   or Ly-6C  lo  . 
For calculation of total cell numbers in the heart, normalization to weight 
of infarct was performed. For assessment of proteolytic activity including 
  cathepsins (  22  ), (Prosense-680, excitation wavelength 680   ±   10 nm, emission 
receptor signature that accompanies recruitment of mono-
cyte subsets in each phase may also constitute a therapeutic 
target; indeed, CCR2 antagonists are currently in clinical trials 
for the treatment of several chronic diseases. The possibility 
of selectively targeting subsets may give rise to monocyte-
based therapeutics for chronic infl  ammatory conditions such 
as atherosclerosis, as well as for improvement of healing after 
acute myocardial infarction. 
  This study points to an active role for circulating Ly-6C  lo   
monocytes during healing and argues against in situ conversion 
as a dominant mechanism by which Ly-6C  lo   cells appear in the 
infarct. Data in support of active recruitment of Ly-6C  lo   cells 
include the following: (a) effi   cient accumulation of adoptively 
transferred Ly-6C  lo   monocytes in infarcts in phase II; (b) the 
absence of Ly-6C  hi   monocytes in phase I, but presence of 
Ly-6C  lo   monocytes in phase II, in infarcts of CCR2    −  /  −    mice; 
and (c) presence of Ly-6C  hi   monocytes in phase I, but absence 
of Ly-6C  lo   monocytes in phase II, in infarcts of CX  3  CR1    –  /  –    
mice. In contrast, according to a proposed model of the response 
to skeletal muscle injury by injection of a neurotoxin, Ly-6C  hi  , 
but not Ly-6C  lo  , monocytes accumulate in injured tissue and 
give rise locally to Ly-6C  lo   F4/80  hi   macrophages (  45  ). The repair 
response and the ensuing recruitment of monocytes might diff  er 
in these two models. Also, we studied tissue recruitment of 
circulating Ly-6C  lo   monocytes at both early and late time points 
and identifi  ed mobilization of these cells only late in infarcts. 
  The near-absence of monocytes in infarct tissue when 
healing ends suggests that long-term retention is rare. Further 
studies need to identify whether monocytes die locally or 
  emigrate from tissue and function beyond initial recruitment. 
Perhaps monocytes recently emigrated from sites of myocar-
dial infarction can accumulate in lymphoid tissue and orches-
trate adaptive immune responses. Because monocytes remain 
relatively undiff  erentiated in infarcts, they may conserve func-
tional plasticity beyond tissue education, and commit only later 
into either macrophages or dendritic cells. 
  Elevated leukocyte counts, including neutrophilia and mono-
cytosis, predict prognosis after MI (  39, 40, 46  –  51  ). Indepen-
dent of infarct size, patients with blood monocytosis display 
left ventricular dilatation, impaired ejection fraction, and will 
more likely develop aneurysms at a 6-mo followup (  39, 40  ). 
These clinical fi  ndings, and the observation in hypercholes-
terolemic mice that peripheral monocytosis and deregulated 
monocyte accumulation in infarcting myocardium leads to 
impaired healing, underscores the need to explore the relevance 
of myocardial monocyte heterogeneity in the human. 
  Overall, this study identifi  es a mechanism of orchestrated 
mobilization of monocyte subtypes, explores the functional con-
sequence of monocyte heterogeneity in infarcting myocardium, 
and proposes that monocyte-based therapeutics harness selective 
targeting of subsets. These observations illuminate some of the 
cellular and molecular mechanisms that underlie the sequence of 
events involved in healing of myocardial infarction; this sequence 
was fi  rst described at a morphological level in the 1930s (  52  ), is 
fundamental to ventricular remodeling, and greatly contributes 
to both acute and chronic complications of MI. JEM VOL. 204, November 26, 2007 
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AAGGACTCACCTTTGCC [Fam-Tamra]), and VCAM-1 (forward, 
TGTAAAAGGAAAAGAACATAACAAGGACTA; reverse, ATGGCAG-
GTATTACCAAGGAAGAT; probe, TTTTCGCCCGAACTCCTTG-
CACTC [Fam-Tamra]) were designed with PrimerExpress (ABI). Standard 
primers and probes for CCR2 and CX3CR1 were purchased from ABI. 
TriZol (Invitrogen) was used to isolate total RNA from infarct tissue samples 
and Oligo(dT) primers to reversely transcribe mRNA into cDNA following 
the manufacturer  ’  s guidelines (SuperScript; Invitrogen). Quantitative PCR 
was performed on an SDS 7000 system (ABI) using ABgene QPCR Rox 
Mix (Epsom) and standard cycling conditions, and cDNA content of samples 
was calculated using the standard curve method. Every sample was run in 
triplicate, and at least three samples per group were assessed.     -Actin was 
chosen as an internal calibrator. 
  Statistics.     Results were expressed as the mean   ±   the SEM. Statistical tests 
included unpaired, two-tailed Student  ’  s   t   test using Welch  ’  s correction for 
unequal variances and one-way analysis of variance, followed by Bonferroni  ’  s 
multiple comparison test. A P value of 0.05 or less was considered to de-
note signifi  cance. 
  Online supplemental material.     Fig. S1 shows that monocytes accumulate 
in the myocardium after MI. Fig. S2 shows the biphasic Ly-6C  hi  :Ly-6C  lo   
response pertains irrespective of monocyte diff  erentiation. Fig. S3 shows 
that splenic and peripheral blood monocytes show comparable phenotypes. 
Table S1 shows that adoptively transferred labeled Ly-6C  hi   compete with 
he endogenous pool. Table S2 shows the function of the biphasic response. 
The online version of this article is available at http://www.jem.org/cgi/
content/full/jem.20070885/DC1. 
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